Alerts will be sent to your verified email
Verify Email
SUDARSHAN
|
Sudarshan Pharma Ind
|
Kilitch Drugs(India)
|
Kopran
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.77 % | 7.31 % | 12.69 % |
|
5yr average Equity Multiplier
|
3.38 | 1.48 | 1.57 |
|
5yr Average Asset Turnover Ratio
|
1.89 | 0.56 | 0.87 |
|
5yr Avg Net Profit Margin
|
2.0 % | 8.44 % | 8.93 % |
|
Price to Book
|
4.34 | 2.17 | 1.28 |
|
P/E
|
38.03 | 20.92 | 36.29 |
|
5yr Avg Cash Conversion Cycle
|
121.83 Days | 14.76 Days | 100.24 Days |
|
Inventory Days
|
54.87 Days | 14.42 Days | 84.74 Days |
|
Days Receivable
|
102.16 Days | 136.16 Days | 123.83 Days |
|
Days Payable
|
70.3 Days | 212.73 Days | 98.33 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 6.02 | 10.74 |
|
5yr Avg ROCE
|
23.07 % | 11.26 % | 17.11 % |
|
5yr Avg Operating Profit Margin
|
4.55 % | 12.28 % | 13.59 % |
|
5 yr average Debt to Equity
|
0.99 | 0.17 | 0.22 |
|
5yr CAGR Net Profit
|
42.99 % | 48.72 % | -8.95 % |
|
5yr Average Return on Assets
|
3.51 % | 4.99 % | 7.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.39 % | 63.77 % | 44.42 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-31.89 % | -4.48 % | 0.17 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sudarshan Pharma Ind
|
Kilitch Drugs(India)
|
Kopran
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|